Hospital Universitari i Politecnic La Fe de Valencia | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction	cardiovascular disorder, heart disorder, heart failure	Recruiting	Phase 3	2026-09-24		NCT06736574
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)	lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder	Recruiting	Phase 3	2026-09-02		NCT07365332
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer	SCLC	Recruiting	Phase 1	2026-08-21		NCT06179069
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 1 / Phase 2	2026-06-30		NCT06162221
Neoadjuvant Darovasertib in Primary Uveal Melanoma	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Uveal Neoplasms, eye disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, ocular cancer, primitive neuroectodermal tumor, skin disorder, skin neoplasm, uveal disorder, uveal melanoma	Recruiting	Phase 3	2026-05-06		NCT07015190
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 2	2025-08-03		NCT05403385